Newcore Gold Ltd. (PCR.V) (CVE:PCR – Get Free Report) Director Barry Johnson Blayne purchased 50,000 shares of the stock in a transaction dated Tuesday, December 24th. The shares were purchased at an average price of C$0.31 per share, for a total transaction of C$15,250.00.
Newcore Gold Ltd. (PCR.V) Stock Up 1.4 %
Shares of PCR stock opened at C$0.74 on Wednesday. The stock has a 50-day simple moving average of C$0.74 and a 200 day simple moving average of C$0.74. The stock has a market capitalization of C$59.16 million and a P/E ratio of -185.00. Newcore Gold Ltd. has a fifty-two week low of C$0.14 and a fifty-two week high of C$0.86.
Newcore Gold Ltd. (PCR.V) Company Profile
Featured Stories
- Five stocks we like better than Newcore Gold Ltd. (PCR.V)
- ETF Screener: Uses and Step-by-Step Guide
- 5 Reasons DraftKings Stock Looks Promising in the New Year
- Stock Splits, Do They Really Impact Investors?
- Cybersecurity Stocks: 1 Immediate Buy and 1 Dip Opportunity
- Expert Stock Trading Psychology Tips
- The Next 2 AI Winners Have Triple-Digit Upside Potential
Receive News & Ratings for Newcore Gold Ltd. (PCR.V) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Newcore Gold Ltd. (PCR.V) and related companies with MarketBeat.com's FREE daily email newsletter.